J&J Vision launches Tecnis Eyhance IOL in EU

This article was originally published here

Johnson & Johnson Vision

Johnson & Johnson (NYSE:JNJ) Vision said today that it launched its Tecnis Eyhance intraocular lens intended to treat cataracts in Europe.

The newly launched next-gen IOL, which has already received CE Mark clearance in the European Union, is designed to provide high-quality vision at both immediate and far distances, which the company touted as “an important first for the monofocal IOL category.”

The Tecnis Eyhance IOL is designed to provide improved intermediate vision when compared with standard aspheric monofocal IOLs, as well as 20/20 distance vision. J&J Vision said that patient-reported outcomes indicated that the Tecnis Eyhance IOL enabled improvements in physical tasks including walking on uneven surfaces and improved engagement in personal activities and hobbies.

“Today, patients with cataracts are forced to make a trade-off decision on their vision when selecting a monofocal intraocular lens. They can have corrected vision at a distance, but require glasses for near and intermediate vision activities, which refers to everything at arm’s length such as computer work or looking at a car speedometer. Tecnis Eyhance IOL offers high quality intermediate as well as distance vision, which is an important advancement to allow patients greater ease in certain activities in their day-to-day lives,”  Dr. Oliver Findl of Hanusch Hospital Vienna said in a prepared statement.

The company said it is launching the device initially in the UK, Italy, France, Spain and Germany.

“With the availability of Tecnis Eyhance IOL in Europe, we are proud to deliver another meaningful solution for patients with cataracts. We saw an opportunity to build upon the legacy of the Tecnis Family of IOLs and the proven design of our 1-piece platform to reimagine what was possible with the standard aspheric monofocal IOL,” J&J Vision surgical worldwide prez Tom Frinzi said in a press release.

Last June, J&J Vision said that the FDA approved its iDesign Refractive Studio for planning lasik eye procedures.

The post J&J Vision launches Tecnis Eyhance IOL in EU appeared first on MassDevice.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply